Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS

Open access
Goodwin, Julie E., Feng, Yan, Velazquez, Heino, Zhou, Han, Sessa, William C. · 2014 · PLoS ONE

Abstract

Glucocorticoids are normally regarded as anti-inflammatory therapy for a wide variety of conditions and have been used with some success in treating sepsis and sepsis-like syndromes. We previously demonstrated that mice lacking the glucocorticoid receptor in the endothelium (GR EC KO mice) are extremely sensitive to low-dose LPS and demonstrate prolonged activation and up regulation of NF-κB. In this study we pre-treated these GR EC KO mice with dexamethasone and assessed their response to an identical dose of LPS. Surprisingly, the GR EC KO mice fared even worse than when given LPS alone demonstrating increased mortality, increased levels of the inflammatory cytokines TNF-α and IL-6 and increased nitric oxide release after the dexamethasone pre-treatment. As expected, control animals pre-treated with dexamethasone showed improvement in all parameters assayed. Mechanistically we demonstrate that GR EC KO mice show increased iNOS production and NF-κB activation despite treatment with dexamethasone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0108126

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Impaired survival in GR EC KO mice after DEX. (A) GR EC KO mice show increased mortality after LPS treatment. (B) Mortality in GR EC KO mice is further increased in GR EC KO mice following DEX pre-treatment while controls are fully rescused following DEX+LPS. (C) Continuous blood pressure monitoring demonstrates hemodynamic instability in GR EC KO mice following pre-treatement with DEX while blood pressure is completely stabilized in control mice. *p<0.05
Figure 1 Impaired survival in GR EC KO mice after DEX. (A) GR EC KO mice show increased mortality after LPS treatment. (B) Mortality in GR EC KO mice is further increased in GR EC KO mice following DEX pre-treatment while controls are fully rescused following DEX+LPS. (C) Continuous blood pressure monitoring demonstrates hemodynamic instability in GR EC KO mice following pre-treatement with DEX while blood pressure is completely stabilized in control mice. *p<0.05CC BY · PubMed Central
Figure 2 Heightened inflammation in GR EC KO mice following DEX pre-treatment. (A) No differences in corticosterone level were observed between GR EC KO mice and controls for any of the conditions tested. (B) Total nitric oxide levels in GR EC KO mice are increased following DEX+LPS. (C) TNF-α and (D) IL-6 levels are significantly increased in GR EC KO mice following DEX+LPS treatment while they are nearly unchanged from baseline in controls. All blood samples were collected 8 hours after LPS treatment (and 10 hours after DEX pre-treatment, if applicable). *p<0.05 compared to similarly treated controls.
Figure 2 Heightened inflammation in GR EC KO mice following DEX pre-treatment. (A) No differences in corticosterone level were observed between GR EC KO mice and controls for any of the conditions tested. (B) Total nitric oxide levels in GR EC KO mice are increased following DEX+LPS. (C) TNF-α and (D) IL-6 levels are significantly increased in GR EC KO mice following DEX+LPS treatment while they are nearly unchanged from baseline in controls. All blood samples were collected 8 hours after LPS treatment (and 10 hours after DEX pre-treatment, if applicable). *p<0.05 compared to similarly treated controls.CC BY · PubMed Central
Figure 3 Lung apopotosis (A) and macrophage infiltration (C) are not improved by DEX in GR EC KO mice. Both GR EC KO mice and controls show an improvement in liver apoptosis (B) and macrophage infiltration (D) following DEX. *p<0.05 compared to similarly treated controls.
Figure 3 Lung apopotosis (A) and macrophage infiltration (C) are not improved by DEX in GR EC KO mice. Both GR EC KO mice and controls show an improvement in liver apoptosis (B) and macrophage infiltration (D) following DEX. *p<0.05 compared to similarly treated controls.CC BY · PubMed Central
Figure 4 Increased iNOS expression and NF-κB activation in GR EC KO mice. Western blot of aortic homogenates from controls and GR EC KO mice treated with LPS alone or DEX+LPS and harvested at the indicated timepoints. Densitometry values are indicated below each lane. Activation of NF-κB was assayed in the same homogenates. (A) Control mice show decreased expression of iNOS when given DEX+LPS as compared to LPS alone and while (B) GR EC KO mice show increased iNOS levels following DEX+LPS as compared to LPS alone. (C) Activation of NF-κB is suppressed following DEX pre-treatement in control animals while in (D) GR EC KO mice increased activation of NF-κB is shown at every time point. *p<0.05 compared to similarly treated control. U = untreated, D = dexamethasone.
Figure 4 Increased iNOS expression and NF-κB activation in GR EC KO mice. Western blot of aortic homogenates from controls and GR EC KO mice treated with LPS alone or DEX+LPS and harvested at the indicated timepoints. Densitometry values are indicated below each lane. Activation of NF-κB was assayed in the same homogenates. (A) Control mice show decreased expression of iNOS when given DEX+LPS as compared to LPS alone and while (B) GR EC KO mice show increased iNOS levels following DEX+LPS as compared to LPS alone. (C) Activation of NF-κB is suppressed following DEX pre-treatement in control animals while in (D) GR EC KO mice increased activation of NF-κB is shown at every time point. *p<0.05 compared to similarly treated control. U = untreated, D = dexamethasone.CC BY · PubMed Central
Figure 5 Expression profile of GRα and GRβ mRNA in endothelial cells. Real time PCR analysis was performed on mouse lung endothelial cells treated as described. Values were normalized to untreated control siRNA GRα levels and represent mean ± SEM for 3 independent samples. Cells were isolated from C57/BL6 mice. *p <0.05 compared to untreated control siRNA GRα levels.
Figure 5 Expression profile of GRα and GRβ mRNA in endothelial cells. Real time PCR analysis was performed on mouse lung endothelial cells treated as described. Values were normalized to untreated control siRNA GRα levels and represent mean ± SEM for 3 independent samples. Cells were isolated from C57/BL6 mice. *p <0.05 compared to untreated control siRNA GRα levels.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 19

Metadata

Authors
Goodwin, J. E., Feng, Y., Velazquez, H., Zhou, H., & Sessa, W. C.
Affiliations
Yale University (US)
Corresponding author
Goodwin, Julie E.
Venue
PLoS ONE
Published
2014-10-09
Volume
9
Issue
10
Pages
e108126
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1987467309
Cited by
19
References
30
Citations by year
2025: 1 · 2022: 1 · 2021: 6 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 1
FWCI
0.85
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Yale University (P30 DK079310)
  • National Institutes of Health (PO1 HL107205, HL107205, HL61371, HL64793, HL081190)
  • National Heart, Lung, and Blood Institute (HL-081190, HL-61371, R01HL096670, HL-64793, R01HL064793, R01HL081190, HL096670, R01HL061371, P01HL107205, R37HL061371)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U24DK59635, U24DK059635, K08DK078623, P30DK079310)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
dexamethasone, lipopolysaccharide, sepsis, NF-κB activation, inducible nitric oxide synthase, nitric oxide, TNF-α, interleukin-6, anti-inflammatory therapy
MeSH terms
Animals, Anti-Inflammatory Agents, Dexamethasone, Endothelium, Glucocorticoids, Lipopolysaccharides, Male, Nitric Oxide, Receptors, Glucocorticoid, Tumor Necrosis Factor-alpha, Interleukin-6, NF-kappa B, Sepsis, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS. https://app.cochat.ai/papers/10.1371/journal.pone.0108126
The paper
Goodwin, J. E., Feng, Y., Velazquez, H., Zhou, H., & Sessa, W. C. (2014). Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS. PLoS ONE. https://doi.org/10.1371/journal.pone.0108126

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.